EPIVIEW— 510(k) K940895
Substantially Equivalent for Some IndicationsConvatec, A Bristol-Myers Squibb Co.
FDA 510(k) clearance K940895 for EPIVIEW, Substantially Equivalent for Some Indications on 1994-11-22. Applicant: Convatec, A Bristol-Myers Squibb Co..
Clearance details
- Applicant
- Convatec, A Bristol-Myers Squibb Co.
- Product code
- Code MGP
- Advisory panel
- Unknown
- Date received
- Decision date
- Decision
- Substantially Equivalent for Some Indications
- Clearance type
- Traditional
- Location
- Skillman, NJ, US
Adverse events under product code MGP
product code MGP- Other
- 1
- Total
- 1
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.